PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.17%
Net income growth under 50% of MRVL's 163.75%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
5.56%
Some D&A expansion while MRVL is negative at -4.39%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
109.86%
Some yoy growth while MRVL is negative at -95.16%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
2.38%
Less SBC growth vs. MRVL's 11.58%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-104.90%
Both reduce yoy usage, with MRVL at -398.19%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
157.14%
AR growth while MRVL is negative at -155.29%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-103.28%
Both reduce yoy inventory, with MRVL at -30.89%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-65.08%
Negative yoy AP while MRVL is 140.17%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-119.08%
Negative yoy usage while MRVL is 57.98%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-260.00%
Negative yoy while MRVL is 122.03%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
6.41%
Operating cash flow growth at 75-90% of MRVL's 7.54%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
71.63%
CapEx growth well above MRVL's 5.28%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
100.00%
Some acquisitions while MRVL is negative at -126.22%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-36950.00%
Negative yoy purchasing while MRVL stands at 83.81%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-32.00%
We reduce yoy sales while MRVL is 25.55%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-171750.00%
Both yoy lines negative, with MRVL at -150.22%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-14695.83%
We reduce yoy invests while MRVL stands at 1024.01%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
77.78%
Debt repayment growth of 77.78% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
100.00%
Issuance growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-1771.43%
Both yoy lines negative, with MRVL at -2537.20%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.